Hillard M Lazarus
Overview
Explore the profile of Hillard M Lazarus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
424
Citations
11721
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lazarus H, Gale R
Best Pract Res Clin Haematol
. 2025 Mar;
37(4):101599.
PMID: 40074513
Radiological accidents/incidents are common with nearly 400 reported since 1944 exposing about 3000 people to substantial doses of ionizing radiations with 127 deaths. Damage to hematopoietic stem and progenitor cells...
2.
Kaplan D, Christian E, Pope S, Lazarus H, Cohen J
Best Pract Res Clin Haematol
. 2025 Mar;
37(4):101596.
PMID: 40074510
Mesenchymal stem/stromal cells (MSC) have been transplanted for therapeutic purposes with inconsistent results. MSC preparations are heterogeneous, and this person-to-person heterogeneity may account for the variable clinical outcomes. Additionally, the...
3.
Kegyes D, Moisoiu V, Constantinescu C, Tanase A, Ghiaur G, Einsele H, et al.
Blood Rev
. 2024 Dec;
69():101254.
PMID: 39674687
Chemo- and immune therapies administered to treat haematologic malignancies frequently cause neurologic injury. The adverse events range from mild cognitive impairment and headaches to severe conditions such as seizures, stroke...
4.
McGuirk J, Metheny 3rd L, Pineiro L, Litzow M, Rowley S, Avni B, et al.
Bone Marrow Transplant
. 2024 Dec;
60(3):425.
PMID: 39627347
No abstract available.
5.
Chung D, Shah N, Wu J, Logan B, Bisharat L, Callander N, et al.
Clin Cancer Res
. 2024 Oct;
30(19):4542.
PMID: 39350638
No abstract available.
6.
Gyurkocza B, Nath R, Seropian S, Choe H, Litzow M, Abboud C, et al.
J Clin Oncol
. 2024 Sep;
43(2):201-213.
PMID: 39298738
Purpose: Older patients with relapsed or refractory AML (RR AML) have dismal prognoses without allogeneic hematopoietic cell transplantation (alloHCT). SIERRA compared a targeted pretransplant regimen involving the anti-CD45 radioconjugate I-apamistamab...
7.
Kahn J, Brazauskas R, Bo-Subait S, Buchbinder D, Hamilton B, Schoemans H, et al.
Lancet Child Adolesc Health
. 2024 Sep;
8(10):740-750.
PMID: 39217999
Background: Continued advances in haematopoietic cell transplantation (HCT) for children with non-malignant diseases (NMDs) have led to a growing population of survivors in whom late occurring toxic effects remain a...
8.
Litzow M, Sun Z, Mattison R, Paietta E, Roberts K, Zhang Y, et al.
N Engl J Med
. 2024 Jul;
391(4):320-333.
PMID: 39047240
Background: Many older adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) have a relapse despite having a measurable residual disease (MRD)-negative complete remission with combination chemotherapy. The addition of blinatumomab,...
9.
Ballen K, Wang T, He N, Knight J, Hong S, Frangoul H, et al.
Transplant Cell Ther
. 2024 Jul;
30(10):1027.e1-1027.e14.
PMID: 39033978
Background: Umbilical cord blood transplant (UCBT) improves access to transplant for patients lacking a fully matched donor. Previous Center for International Blood and Marrow Transplant Research (CIBMTR) showed that Black...
10.
Balciuniene J, Ning Y, Lazarus H, Aikawa V, Sherpa S, Zhang Y, et al.
Blood Rev
. 2024 Jun;
66:101209.
PMID: 38852016
Since the discovery of the Philadelphia chromosome in 1960, cytogenetic studies have been instrumental in detecting chromosomal abnormalities that can inform cancer diagnosis, treatment, and risk assessment efforts. The initial...